Similar Posts
How this rare disease biotech is reshaping the future and why investors are paying close attention 💡
Zevra Therapeutics has recently made a series of notable announcements that have captured the attention of investors, analysts, and those following developments in the rare disease pharmaceuticals sector. As it undertakes strategic organizational shifts, reports strong financial metrics, and earns supportive analyst forecasts, the company appears committed to building a robust pipeline of treatments for…
DOT: Vehicle Miles Driven Increased 1.5% year-over-year
by Calculated Risk on 8/19/2025 01:11:00 PM This is something I check occasionally. The Department of Transportation (DOT) reported: Travel on all roads and streets changed by +1.5% (+4.1 billion vehicle miles) for April 2025 as compared with April 2024. Travel for the month is estimated to be 277.3 billion vehicle miles. The seasonally adjusted…
Stellus Capital Stock: The 12% Yield Could Be At Risk (Downgrade) (NYSE:SCM)
Stellus Capital: The 12% Yield Could Be At Risk (Rating Downgrade) Source link
DU Digital under Sebi scanner: Regulator bars 26 individuals, slaps penalty after SME stock rallies 1,393%
Market regulator Securities and Exchange Board of India (Sebi) has barred 26 individuals from accessing the capital markets for up to 2 years after finding them involved in price manipulation of SME stock DU Digital Technologies Limited. The regulator also directed disgorgement of Rs 98.78 lakh made by them as unlawful gains while slapping a…
